Clinical Research Directory
Browse clinical research sites, groups, and studies.
IV Administration of ChromaDex's Niagen® as Compared to NAD+
Sponsor: Nutraceuticals Research Institute
Summary
This is a 2-part study evaluating the effects of IV administration of NR on healthy adult populations. Study 1 involved all four arms with 37 people. The second study only included the active NR and NAD+ arms to further evaluate tolerability and comfort of the IV.
Official title: The Effects of IV Administration of ChromaDex's Niagen®, Nicotinamide Riboside Chloride as Compared to IV Administration of NAD+: A Randomized, Placebo Controlled Clinical Trial
Key Details
Gender
All
Age Range
40 Years - Any
Study Type
INTERVENTIONAL
Enrollment
53
Start Date
2023-11-13
Completion Date
2024-08-31
Last Updated
2024-04-24
Healthy Volunteers
Yes
Conditions
Interventions
NAD+ (nicotinamide adenine dinucleotide) IV
NAD+ enables cells to generate cellular energy from the food that one eats
Niagen® (nicotinamide riboside) IV
NR is a unique member of the vitamin B3 family. Cells can use NR to create nicotinamide adenine dinucleotide (NAD+), which is an essential molecule found in every living cell. Patients in this arm received an IV administration.
Niagen® (nicotinamide riboside) oral
NR is a unique member of the vitamin B3 family. Cells can use NR to create nicotinamide adenine dinucleotide (NAD+), which is an essential molecule found in every living cell. Patients in this arm received an oral administration.
Placebo
These individuals received a saline IV
Locations (1)
Nutraceuticals Research Institute
Franklin, Tennessee, United States